Adjuvant Sunitinib in Renal-Cell Carcinoma

被引：4
|
作者：
Zhang, Sheng [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 09期
关键词：
RISK;
D O I：
10.1056/NEJMc1616636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：893 / 893
页数：1
相关论文
共 50 条
  • [1] Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
    Ravaud, A.
    Motzer, R. J.
    Pandha, H. S.
    George, D. J.
    Pantuck, A. J.
    Patel, A.
    Chang, Y. -H.
    Escudier, B.
    Donskov, F.
    Magheli, A.
    Carteni, G.
    Laguerre, B.
    Tomczak, P.
    Breza, J.
    Gerletti, P.
    Lechuga, M.
    Lin, X.
    Martini, J. -F.
    Ramaswamy, K.
    Casey, M.
    Staehler, M.
    Patard, J. -J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (23): : 2246 - 2254
  • [2] Sunitinib in renal-cell carcinoma: expanded indications
    Choueiri, Toni K.
    Bellmunt, Joaquim
    LANCET ONCOLOGY, 2009, 10 (08): : 740 - 740
  • [3] Pazopanib or sunitinib for metastatic renal-cell carcinoma?
    Bennet, Neil
    LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
  • [4] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy
    Klatte, Tobias
    EUROPEAN UROLOGY, 2017, 71 (05) : 835 - 836
  • [5] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Salmasi, Amirali
    Faiena, Izak
    Drakaki, Alexandra
    Pantuck, Allan J.
    EUROPEAN UROLOGY, 2018, 74 (01) : 119 - 121
  • [6] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Ravaud, A.
    Motzer, R. J.
    Pandha, H. S.
    UROLOGY, 2017, 105 : 13 - 13
  • [7] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Struss, Werner J.
    Black, Peter C.
    UROLOGY, 2017, 105 : 13 - 13
  • [8] Adjuvant Pembrolizumab in Renal-Cell Carcinoma
    Chakiryan, Nicholas H.
    Strother, Marshall C.
    Choueiri, Toni K.
    Powles, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 185 - 186
  • [9] Sunitinib as adjuvant therapy for renal cell carcinoma
    Baker, Holly
    LANCET ONCOLOGY, 2016, 17 (11): : E485 - E485
  • [10] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
12345